ClaudineIsaacsMDFRCPC

PubMed

• A scoping review of web-based, interactive, personalized decision-making tools available to support breast cancer treatment and survivorship care.
  Kaitlyn M Wojcik, Dalya Kamil, Julia Zhang, Oliver W A Wilson, Laney Smith, Gisela Butera, Allison Kurian, Jinani Jayasekera, Claudine Isaacs> ;Journal of Cancer Survivorship. 2024 Mar 28
• NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer.
  Taylor, B., Sun, X., Gonzalez-Ericsson, P., Sanchez, V., Sanders, M., Wescott, E., Opalenik, S., Hanna, A., Chou, S., Van Kaer, L., Gomez, H., Isaacs, C., Ballinger, T...> ;Cancer Discovery. 2024 Feb 8
• Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique.
  Emily J Gallagher, Heather Moore, Mario E Lacouture, Susan F Dent, Azeez Farooki, Marcus D Goncalves, Claudine Isaacs, Abigail Johnston, Dejan Juric, Zoe Quandt, Laura...> ;NPJ Breast Cancer. 2024 Jan 31
• 1 citations
  Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical...
  Lehmann, B., Abramson, V., Dees, E., Shah, P., Ballinger, T., Isaacs, C., Santa-Maria, C., An, H., Gonzalez-Ericsson, P., Sanders, M., Newsom, K., Abramson, R., Sheng,...> ;JAMA Oncology. 2024 Feb 1
• 1 citations
  Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial.
  Gallagher, R., Wulfkuhle, J., Wolf, D., Brown-Swigart, L., Yau, C., O'Grady, N., Basu, A., Lu, R., Campbell, M., Magbanua, M., Coppé, J., , Asare, S., Sit, L., Matthew...> ;Cell Reports. Medicine. 2023 Dec 19
• 1 citations
  Results of a randomized controlled trial of a decision support intervention for disclosing maternalgenetic test results to children and adolescents.
  Kenneth P Tercyak, Tiffani A DeMarco, Katherine A Schneider, George Luta, Claudine Isaacs, Judy E Garber, Marcelo M Sleiman Jr, Mary Rose Yockel, Beth N Peshkin> ;PEC Innovation. 2023 Dec 1
• Pilot Trial of Streamlined Genetic Education and Traceback Genetic Testing in Prostate Cancer Survivors.
  Schwartz, M., Peshkin, B., Grisham, C., Holmes, N., Sorgen, L., McGuire, C., Newell, K., Kolla, K., Weinstein, V., Isaacs, C., Collins, S., Dawson, N., Okobi, T.> ;Journal of the National Comprehensive Cancer Network. 2023 Dec 1
• 1 citations
  Depressive symptom trajectories in older breast cancer survivors: the Thinking and Living with Cancer Study.
  Zev M Nakamura, Brent J Small, Wanting Zhai, Tim A Ahles, Jaeil Ahn, Ashley L Artese, Traci N Bethea, Elizabeth C Breen, Harvey J Cohen, Martine Extermann, Deena Graha...> ;Journal of Cancer Survivorship. 2023 Nov 4
• Adherence to hormonal therapy after surgery among older women with ductal carcinoma in situ: Implications for breast cancer-related adverse health events.
  Jean M Mitchell, Thomas DeLeire, Claudine Isaacs> ;Cancer. 2024 Jan 1
• Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer.
  Neelam V Desai, Elizabeth D Barrows, Sarah M Nielsen, Kathryn E Hatchell, Michael J Anderson, Eden V Haverfield, Blanca Herrera, Anneke Lucassen, Nadine M Tung, Claudi...> ;JCO Precision Oncology. 2023 Aug 1
• 2 citations
  A phase I trial of palbociclib and bosutinib with fulvestrant in patients with metastatic hormone receptor positive and HER2 negative (HR+ HER2-) breast cancer refract...
  Tina Roy, Elizabeth Barrows, Candace Mainor, Julie Collins, Filipa Lynce, Claudine Isaacs, Paula R Pohlmann> ;Contemporary Clinical Trials Communications. 2023 Jun 1
• 3 citations
  Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer.
  Rikki A Cannioto, Kristopher M Attwood, Evan W Davis, Lucas A Mendicino, Alan Hutson, Gary R Zirpoli, Li Tang, Nisha M Nair, William Barlow, Dawn L Hershman, Joseph M ...> ;JAMA Network Open. 2023 May 1
• Plasma levels of interleukin-6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study.
  Jeanne S Mandelblatt, Brent J Small, Xingtao Zhou, Zev M Nakamura, Harvey J Cohen, Tim A Ahles, Jaeil Ahn, Traci N Bethea, Martine Extermann, Deena Graham, Claudine Is...> ;Cancer. 2023 Aug 1
• 1 citations
  An 8-week exercise study to improve cancer treatment related fatigue and QOL among African American breast cancer patients undergoing radiation treatment: A pilot rand...
  Lucile L Adams-Campbell, Jennifer Hicks, Kepher Makambi, Pamela Randolph-Jackson, Mary Mills, Claudine Isaacs, Chiranjeev Dash> ;Journal of the National Medical Association. 2023 Apr 1
• Measuring high-risk parents' opinions about direct-to-consumer genetic testing for adult-onset inherited cancer syndromes in their adolescent and young adult children.
  Emily Hasser, Beth N Peshkin, Jada G Hamilton, Jamie Brower, Hannah Ovadia, Lainie Friedman Ross, Rosalba Sacca, Beth Tarini, Susan M Domchek, Sarah Vittone, Marcelo S...> ;Journal of Genetic Counseling. 2023 Aug 1
• 3 citations
  BRCA1 deficiency in mature CD8T lymphocytes impairs antitumor immunity.
  Bogang Wu, Leilei Qi, Huai-Chin Chiang, Haihui Pan, Xiaowen Zhang, Alexandra Greenbaum, Elizabeth Stark, Li-Ju Wang, Yidong Chen, Bassem R Haddad, Dionyssia Clagett, C...> ;Journal for Immunotherapy of Cancer. 2023 Feb 1
• 8 citations
  Elevated C-Reactive Protein and Subsequent Patient-Reported Cognitive Problems in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study.
  Judith E Carroll, Zev M Nakamura, Brent J Small, Xingtao Zhou, Harvey J Cohen, Tim A Ahles, Jaeil Ahn, Traci N Bethea, Martine Extermann, Deena Graham, Claudine Isaacs...> ;Journal of Clinical Oncology. 2023 Jan 10
• 26 citations
  Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.
  Susana Garcia-Recio, Toshinori Hinoue, Gregory L Wheeler, Benjamin J Kelly, Ana C Garrido-Castro, Tomas Pascual, Aguirre A De Cubas, Youli Xia, Brooke M Felsheim, Marn...> ;Nature Cancer. 2023 Jan 1
• 2 citations
  Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor-Positive Breast Cancer.
  Jinani Jayasekera, Amy Zhao, Kathryn Lowry, Jennifer M Yeh, Marc D Schwartz, Suzanne O'Neill, Karen J Wernli, Natasha Stout, Jeanne Mandelblatt, Allison W Kurian, Clau...> ;Journal of Clinical Oncology. 2023 Feb 1
• 6 citations
  Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.
  Julie E Lang, Andres Forero-Torres, Douglas Yee, Christina Yau, Denise Wolf, John Park, Barbara A Parker, A Jo Chien, Anne M Wallace, Rashmi Murthy, Kathy S Albain, Er...> ;NPJ Breast Cancer. 2022 Dec 1
• 3 citations
  HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving...
  Paula R Pohlmann, Deena Graham, Tianmin Wu, Yvonne Ottaviano, Mahsa Mohebtash, Shweta Kurian, Donna McNamara, Filipa Lynce, Robert Warren, Asma Dilawari, Suman Rao, Ca...> ;Breast Cancer Research and Treatment. 2022 Dec 1
• 1 citations
  Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.
  Dhawan, M. S., Hakkaart, C., Pearson, J., Marquart, L., Dennis, J., Wiggins, G., Barnes, D., Robinson, B., Mace, P., Aittomäki, K., Andrulis, I., Arun, B., Azzollini, ...> ;Communications Biology. 2022 Oct 6
• 3 citations
  Molecular characterization of ESR1 variants in breast cancer.
  Arielle L Heeke, Andrew Elliott, Rebecca Feldman, Hazel F O'Connor, Paula R Pohlmann, Filipa Lynce, Sandra M Swain, Maria R Nunes, Daniel Magee, Matthew J Oberley, Jef...> ;Breast Cancer Research and Treatment. 2022 Nov 1
• 4 citations
  Long-Term Adaptation Among Adolescent and Young Adult Children to Familial Cancer Risk.
  Glynnis A McDonnell, Beth N Peshkin, Tiffani A DeMarco, Susan K Peterson, Banu K Arun, Susan Miesfeldt, Suzanne C O'Neill, Katherine Schneider, Judy Garber, Claudine I...> ;Pediatrics. 2022 Aug 1
• 6 citations
  Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study.
  James C Root, Xingtao Zhou, Jaeil Ahn, Brent J Small, Wanting Zhai, Traci Bethea, Judith E Carroll, Harvey Jay Cohen, Asma Dilawari, Martine Extermann, Deena Graham, C...> ;Breast Cancer Research and Treatment. 2022 Jul 1
• Join now to see all

Journal Articles

• Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy with Disease Recurrence in Patients with Triple-Negative Breast Cancer  
  Rita Nanda, Carla Falkson, Filipa C Lynce, Claudine Isaacs, Marcelo Blaya, Elisavet Paplomata, Radhika Walling, Reshma Mahtani, Tarah J Ballinger, Kathy D Miller, Brya..., JAMA Oncology

Other

• Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations 
  Isaacs C, Peshkin BN, Fletcher SW
  http://www.uptodate.com/contents/management-of-hereditary-breast-and-ovarian-cancer-syndrome-and-pat
  UpToDate, Wolters Kluwer Health - 2013-04-10
• Characteristics of hereditary breast and ovarian cancer syndromes 
  Isaacs C, Peshkin BN
  http://www.uptodate.com/contents/characteristics-of-hereditary-breast-and-ovarian-cancer-syndromes
  UpToDate, Wolters Kluwer Health - 2012-12-11
• Genetic risk assessment for individuals at risk for hereditary breast and ovarian cancer syndromes 
  Isaacs C, Peshkin BN
  http://www.uptodate.com/contents/genetic-risk-assessment-for-individuals-at-risk-for-hereditary-brea
  UpToDate, Wolters Kluwer Health - 2013-02-12
• Genetic testing for hereditary breast and ovarian cancer syndrome 
  Isaacs C, Peshkin BN, Fletcher SW
  http://www.uptodate.com/contents/genetic-testing-for-hereditary-breast-and-ovarian-cancer-syndrome
  UpToDate, Wolters Kluwer Health - 2012-08-13
• Join now to see all